Medtronic plc (VIE:MDT)

Medtronic Statistics

Total Valuation

Medtronic has a market cap or net worth of EUR 104.11 billion. The enterprise value is 121.95 billion.

Market Cap	104.11B
Enterprise Value	121.95B

Important Dates

The next estimated earnings date is Tuesday, November 18, 2025.

Earnings Date	Nov 18, 2025
Ex-Dividend Date	Sep 26, 2025

Share Statistics

Current Share Class	1.28B
Shares Outstanding	n/a
Shares Change (YoY)	-2.52%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	86.45%
Float	1.28B

Valuation Ratios

The trailing PE ratio is 26.22 and the forward PE ratio is 16.43.

PE Ratio	26.22
Forward PE	16.43
PS Ratio	3.57
PB Ratio	2.54
P/TBV Ratio	n/a
P/FCF Ratio	23.04
P/OCF Ratio	17.10
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.53, with an EV/FCF ratio of 26.99.

EV / Earnings	30.71
EV / Sales	4.14
EV / EBITDA	14.53
EV / EBIT	21.43
EV / FCF	26.99

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.59.

Current Ratio	2.01
Quick Ratio	1.25
Debt / Equity	0.59
Debt / EBITDA	2.94
Debt / FCF	5.39
Interest Coverage	8.95

Financial Efficiency

Return on equity (ROE) is 9.74% and return on invested capital (ROIC) is 5.40%.

Return on Equity (ROE)	9.74%
Return on Assets (ROA)	4.57%
Return on Invested Capital (ROIC)	5.40%
Return on Capital Employed (ROCE)	8.31%
Revenue Per Employee	306,720
Profits Per Employee	41,793
Employee Count	95,000
Asset Turnover	0.38
Inventory Turnover	2.10

Taxes

In the past 12 months, Medtronic has paid 827.29 million in taxes.

Income Tax	827.29M
Effective Tax Rate	17.15%

Stock Price Statistics

The stock price has decreased by -0.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-0.67%
50-Day Moving Average	80.62
200-Day Moving Average	79.67
Relative Strength Index (RSI)	47.97
Average Volume (20 Days)	3

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.52

Income Statement

In the last 12 months, Medtronic had revenue of EUR 29.14 billion and earned 3.97 billion in profits. Earnings per share was 3.08.

Revenue	29.14B
Gross Profit	19.05B
Operating Income	5.63B
Pretax Income	4.82B
Net Income	3.97B
EBITDA	8.05B
EBIT	5.63B
Earnings Per Share (EPS)	3.08

Balance Sheet

The company has 6.92 billion in cash and 24.37 billion in debt, giving a net cash position of -17.44 billion.

Cash & Cash Equivalents	6.92B
Total Debt	24.37B
Net Cash	-17.44B
Net Cash Per Share	n/a
Equity (Book Value)	41.01B
Book Value Per Share	31.83
Working Capital	9.96B

Cash Flow

In the last 12 months, operating cash flow was 6.09 billion and capital expenditures -1.57 billion, giving a free cash flow of 4.52 billion.

Operating Cash Flow	6.09B
Capital Expenditures	-1.57B
Free Cash Flow	4.52B
FCF Per Share	n/a

Margins

Gross margin is 65.38%, with operating and profit margins of 19.31% and 13.63%.

Gross Margin	65.38%
Operating Margin	19.31%
Pretax Margin	16.55%
Profit Margin	13.63%
EBITDA Margin	27.62%
EBIT Margin	19.31%
FCF Margin	15.51%

Dividends & Yields

This stock pays an annual dividend of 2.54, which amounts to a dividend yield of 3.14%.

Dividend Per Share	2.54
Dividend Yield	3.14%
Dividend Growth (YoY)	-0.47%
Years of Dividend Growth	1
Payout Ratio	82.20%
Buyback Yield	2.52%
Shareholder Yield	5.57%
Earnings Yield	3.81%
FCF Yield	4.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medtronic has an Altman Z-Score of 2.82 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.82
Piotroski F-Score	6